How We Believe Kenilin will work

Kenilin simplifies how wounds are treated. In doing this it transforms how wounds have been classically treated. Kenilin is put on at home twice a day by the patient, covered with a breathable bandage, and simply left alone - no more debridement, no more daily visits, no more complex and costly treatments. Many patients with intractable pain are soon able to taper off of pain medications. Most patients are able to get off of antibiotics, even patients with cultures of pathogenic organisms such as MRSA.

Difficult to heal wounds

At the present time, chronic wound management is extremely time consuming, painful and expensive. Millions of patients are involved. And failure is common, too often leading to surgical intervention and amputation.  The use of and application of Kenilin to the chronic wound simplifies management, relieves pain, reduces or eliminates the need for antibiotics, and reduces cost. Wounds begin to rapidly heal. As Kenilin is anti-inflammatory and analgesic, patient compliance and caretaker participation is improved. Need for debridement, which up to now has been a hallmark of wound management, is commonly eliminated. Debridement is the surgical removal of skin and tissue around a wound to aid in healing. In doing so, however, the wound is commonly enlarged and frequently slows healing.

It is important to understand that no other wound product on the market has ever been tested and found to be effective on the worst-case scenario patients, diabetic patients on dialysis. Normally, physicians would use debridement to treat chronic wounds. But debridement enlarges wounds in the process of healing them. Physicians are hesitant to enlarge wounds of dialysis or diabetic patients, as there is high potential that these patients may not be able to then go on to shrink and heal these wounds. Also, antibiotics and pain drugs are often a burden on the kidneys in patients already with compromised renal function. Thus, the FDA was particularly interested and very encouraging of the developers of Kenilin as we plan to test Kenilin on diabetic patients on dialysis, healing their wounds without debridement, antibiotics or pain medications.

All Wounds

Once Kenilin is shown to be effective on very difficult to treat wound patients, Kenilin’s applicability will then be expanded to include multiple patient wound populations.